Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System

Company begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leadership strengthened with key appointmentDUBLIN, ...

Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that senior ...
Seeking Alpha

Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial ...

DUBLIN, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
Seeking Alpha

Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor

DUBLIN, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
Silicon Republic

Wicklow’s Trinity Biotech secures $25m in SEPA funding

Irish health diagnostic solutions company Trinity Biotech has secured new funding of up to $25m through a standby equity purchase agreement with Yorkville Advisors.
Nasdaq

Trinity Biotech Projects Continued Path to Adjusted EBITDA Profitability Starting Q3 2025

Trinity Biotech plc announced that it has achieved Adjusted EBITDA-positive operations during Q2 2025 and expects to maintain this positive trajectory going forward, marking a key milestone in its ...

Trinity Biotech plc: Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform

Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronics ...
Benzinga.com

Why Is Trinity Biotech Stock Soaring Tuesday?

Trinity Biotech plc (NASDAQ: TRIB) stock surged Tuesday after the diagnostics company announced a pair of developments that significantly altered its near- and long-term outlook. Investors reacted ...
Morningstar

Trinity Biotech Appoints Paul Tivnan as Non-Executive Director

Trinity Biotech does not undertake and specifically disclaims any obligation to update any forward-looking statements. About Trinity Biotech Trinity Biotech is a commercial stage biotechnology company ...
Morningstar

Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial ...

Trinity Biotech does not undertake and specifically disclaims any obligation to update any forward-looking statements. About Trinity Biotech Trinity Biotech is a commercial stage biotechnology company ...

Trinity Biotech plc: Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c ...

Company begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leadership strengthened with key appointment DUBLIN, March 12, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc ...